Compare BHVN & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | CBL |
|---|---|---|
| Founded | 2013 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2022 | 1995 |
| Metric | BHVN | CBL |
|---|---|---|
| Price | $13.52 | $47.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 1 |
| Target Price | $29.08 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 3.2M | 227.6K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.00% |
| EPS Growth | 26.08 | ★ 132.09 |
| EPS | N/A | ★ 1.48 |
| Revenue | N/A | ★ $578,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.82 |
| Revenue Growth | N/A | ★ 12.18 |
| 52 Week Low | $7.48 | $25.30 |
| 52 Week High | $18.57 | $50.98 |
| Indicator | BHVN | CBL |
|---|---|---|
| Relative Strength Index (RSI) | 69.34 | 51.39 |
| Support Level | $13.41 | $46.80 |
| Resistance Level | $13.54 | $48.91 |
| Average True Range (ATR) | 0.91 | 1.34 |
| MACD | 0.26 | -0.30 |
| Stochastic Oscillator | 81.98 | 27.42 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.